EDIT
Editas Medicine·NASDAQ
--
--(--)
--
--(--)
3.79 / 10
Netural
Analyst sentiment is overwhelmingly bullish with two Strong Buy calls, yet both analysts have zero historical win rates and negative average returns. Fund‑flow scores 7.57/10, showing strong inflows in small to large investors but overall negative trend. The mixed signals temper optimism.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-09
InstitutionChardan Capital
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for EDIT?
- EDIT holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.79/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
